Slides on Navigating Insulin-based Therapy

Apply new studies on NPH, regular insulin, switching, and other approaches to avoid hypoglycemia, control hyperglycemia, and reduce CV risk with this downloadable slideset.
Veronica K. Piziak, MD, PhD, FACP
Program Director
Format: Microsoft PowerPoint (.ppt)
File Size: 310 KB
Released: December 10, 2018


Provided by Southern Medical Association
Southern Medical Association logo

Southern Medical Association, CME Division
3500 Blue Lake Drive, Suite 360
Birmingham, AL 35243
Tel: 800.423.4992, ext. 620

Supported by an educational grant from
Lilly USA, LLC

Related Content

Learn about obesity management for long-term weight loss and CVD risk reduction; focus on new and emerging incretin therapies, eg, GLP-1 agonists, from Clinical Care Options (CCO)

person default Fatima Cody Stanford, MD, MPH, MPA, MBA Released: June 8, 2021

CCO Slides on T2D: Latest expert advice on SGLT2 inhibitors to prevent and manage heart failure, including HFrEF and HFpEF, in type 2 diabetes.

Jennifer B. Green, MD Mikhail N. Kosiborod, MD Released: June 7, 2021

Randy Seeley, PhD: Thoughts on body weight set points and how they affect obesity and its management from Clinical Care Options (CCO)

Randy J. Seeley, PhD Released: May 4, 2021

Jenny Tong, MD, MPH, answers questions about GLP-1 receptor agonists for weight loss treatment duration and weight stability and use in patients with obesity and related comorbidities

Jenny Tong, MD, MPH Released: May 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.